Influence of coagulation and anticoagulant factors on global coagulation assays in healthy adults

American Journal of Clinical Pathology

Volumn 139, Issue 3, 2013, Pages 370-379

  Kim, Seon Young ^a   Kim, Ji Eun ^a   Kim, Hyun Kyung ^a   Kim, Inho ^a   Yoon, Sung Soo ^a   Park, Seonyang ^a  

^a Seoul National University   (South Korea)

Author keywords

Activated partial thromboplastin time; Anticoagulant factor; Coagulation; Factor; Global coagulation assay; Prothrombin time; Thrombin generation assay; Vitamin K

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING INHIBITOR; FIBRINOGEN; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBIN; TRIACYLGLYCEROL; VITAMIN K GROUP;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD LEVEL; FEMALE; HUMAN; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; REFERENCE VALUE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; BLOOD CLOTTING TEST; MIDDLE AGED;

ADULT; AGED; ANTITHROMBINS; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; FEMALE; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

MLCS; MLOWN;

EID: 84875902996     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPC5C4AGFRDKMX     Document Type: Article

References (39)

1. Kitchens CS. To bleed or not to bleed? Is that the question for the PTT? J Thromb Haemost. 2005;3:2607-2611.
2. Tripodi A, Legnani C, Chantarangkul V, et al. High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism. J Thromb Haemost. 2008;6:1327-1333.
3. Al Dieri R, Peyvandi F, Santagostino E, et al. The thrombogram in rare inherited coagulation disorders: Its relation to clinical bleeding. Thromb Haemost. 2002;88:576-582.
4. Hron G, Kollars M, Binder BR, et al. Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA. 2006;296:397-402.
5. Matsumoto T, Shima M, Takeyama M, et al. The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay. J Thromb Haemost. 2006;4:377-384.
6. Simioni P, Castoldi E, Lunghi B, et al. An underestimated combination of opposites resulting in enhanced thrombotic tendency. Blood. 2005;106:2363-2365.
7. Dargaud Y, Trzeciak MC, Bordet JC, et al. Use of calibrated automated thrombinography +/-thrombomodulin to recognise the prothrombotic phenotype. Thromb Haemost. 2006;96:562-567.
8. Brandts A, van Hylckama Vlieg A, Rosing J, et al. The risk of venous thrombosis associated with a high endogenous thrombin potential in the absence and presence of activated protein C. J Thromb Haemost. 2007;5:416-418.
9. Castoldi E, Govers-Riemslag JW, Pinotti M, et al. Coinheritance of factor V (FV) Leiden enhances thrombin formation and is associated with a mild bleeding phenotype in patients homozygous for the FVII 9726+5G>A (FVII Lazio) mutation. Blood. 2003;102:4014-4020.
10. Dargaud Y, Béguin S, Lienhart A, et al. Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Thromb Haemost. 2005;93:475-480.
11. Besser M, Baglin C, Luddington R, et al. High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study. J Thromb Haemost. 2008;6:1720-1725.
12. Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med. 2000;343:457-462.
13. Meijers JC, Tekelenburg WL, Bouma BN, et al. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med. 2000;342:696-701.
14. van Hylckama Vlieg A, van der Linden IK, Bertina RM, et al. High levels of factor IX increase the risk of venous thrombosis. Blood. 2000;95:3678-3682.
15. de Visser MC, Poort SR, Vos HL, et al. Factor X levels, polymorphisms in the promoter region of factor X, and the risk of venous thrombosis. Thromb Haemost. 2001;85:1011-1017.
16. Jenkins PV, Rawley O, Smith OP, et al. Elevated factor VIII levels and risk of venous thrombosis. Br J Haematol. 2012;157:653-663.
17. Allen GA, Wolberg AS, Oliver JA, et al. Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system. J Thromb Haemost. 2004;2:402-413.
18. Dielis AW, Castoldi E, Spronk HM, et al. Coagulation factors and the protein C system as determinants of thrombin generation in a normal population. J Thromb Haemost. 2008;6:125-131.
19. Duchemin J, Pan-Petesch B, Arnaud B, et al. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma. Thromb Haemost. 2008;99:767-773.
20. Machlus KR, Colby EA, Wu JR, et al. Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram. Thromb Haemost. 2009;102:936-944.
21. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood. 1987;70:165-172.
22. Andrew M, Vegh P, Johnston M, et al. Maturation of the hemostatic system during childhood. Blood. 1992;80:1998-2005.
23. Butenas S, van't Veer C, Mann KG. "Normal" thrombin generation. Blood. 1999;94:2169-2178.
24. Coller BS, Owen J, Jesty J, et al. Deficiency of plasma protein S, protein C, or antithrombin III and arterial thrombosis. Arteriosclerosis. 1987;7:456-462.
25. Bovill EG, Bauer KA, Dickerman JD, et al. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood. 1989;73:712-717.
26. Lowe GD, Rumley A, Woodward M, et al. Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey: I, illustrative reference ranges by age, sex and hormone use. Br J Haematol. 1997;97:775-784.
27. Park KJ, Kwon EH, Ma Y, et al. Significantly different coagulation factor activities underlying the variability of "normal" activated partial thromboplastin time. Blood Coagul Fibrinolysis. 2012;23:35-38.
28. Seo JW, Kim HK, Kim JE, et al. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation. Thromb Res. 2009;123:565-572.
29. Favaloro EJ, Soltani S, McDonald J, et al. Cross-laboratory audit of normal reference ranges and assessment of ABO blood group, gender and age on detected levels of plasma coagulation factors. Blood Coagul Fibrinolysis. 2005;16:597-605.
30. Jang JH, Seo JY, Bang SH, et al. Establishment of reference intervals for von Willebrand factor antigen and eight coagulation factors in a Korean population following the Clinical and Laboratory Standards Institute guidelines. Blood Coagul Fibrinolysis. 2010;21:251-255.
31. Hemker HC, Giesen P, Al Dieri R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb. 2003;33:4-15.
32. Vanschoonbeek K, Feijge MA, Van Kampen RJ, et al. Initiating and potentiating role of platelets in tissue factorinduced thrombin generation in the presence of plasma: Subject-dependent variation in thrombogram characteristics. J Thromb Haemost. 2004;2:476-484.
33. Gerotziafas GT, Depasse F, Busson J, et al. Towards a standardization of thrombin generation assessment: The influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay. Thromb J. 2005;3:16.
34. D'Angelo A, Della Valle P, Crippa L, et al. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment. Haematologica. 2002;87:1074-1080.
35. Hemker HC, Beguin S. Thrombin generation in plasma: Its assessment via the endogenous thrombin potential. Thromb Haemost. 1995;74:134-138.
36. Hron G, Eichinger S, Weltermann A, et al. Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time. J Thromb Haemost. 2006;4:752-756.
37. van't Veer C, Mann KG. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II. J Biol Chem. 1997;272:4367-4377.
38. Hoffman CJ, Lawson WE, Miller RH, et al. Correlation of vitamin K-dependent clotting factors with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb. 1994;14:1737-1740.
39. Luddington R, Baglin T. Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. J Thromb Haemost. 2004;2:1954-1959.